Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 206

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 206
---
 interest of COVIRIX, at a deemed price per share of US$6,
representing an aggregate amount of US$617,340,000. Simultaneously, it is proposed that COVIRIX undertakes to introduce investors to
raise US$6 million at US$6 per share for NIVF, in a form mutually acceptable to both NewGen and COVIRIX. Following stockholder approval
of the Proposed Transaction, COVIRIX Shareholders are expected to hold approximately 85.8% equity interest in NewGen. However, on September
21, 2024, COVIRIX withdrew from the Proposed Transaction, as such the Proposed Transaction was terminated with no cost to the Company.

On August 7, 2024, the Company
entered into a Securities Purchase Agreement with certain investors named therein (collectively, the “Buyers”), pursuant
to which, amongst other things: (i) the Company agreed to sell, at an initial closing with JAK Opportunities VI LLC (“JAK”
and such initial closing, the “Initial Closing”), pursuant to which the Company agreed to sell to JAK (a) a senior convertible
note (the “Initial Note”) in the aggregate original principal amount of $1,100,000, and which terms are further set forth
below under the subheading “(ii) Initial Closing with JAK”, (b) a warrant to purchase 1,325,301 Class A Ordinary Shares of
the Company (subject to Reverse Stock Split adjustments), no par value (“Class A Shares” and such warrant, the Series A Warrant),
and (c) a warrant to purchase 180,722 Class B Ordinary Shares (subject to Reverse Stock Split adjustments) of the Company, no par value
(“Class B Shares” and such warrant, the Series B Warrant, and the Series B Warrants, together with the Series A Warrants,
the “Warrants”); and (ii) the Company may require each Buyer (or each Buyer may require the Company, as applicable) to participate
in the sale of (a) one or more additional convertible notes (which aggregate original principal amount for all additional convertible
notes shall not exceed $9,500,000) (the “Additional Notes,” and, together with the Initial Note, the “Notes”).

On August 12, 2024, the
Company and JAK consummated the Initial Closing. The Initial Note sold to JAK in connection with